Why KFF Is Launching a Podcast on the Business of Health
To kick off KFF’s Business of Health with Chip Kahn, KFF’s Drew Altman explains how…
Why KFF Is Launching a Podcast on the Business of Health
To kick off KFF’s Business of Health with Chip Kahn, KFF’s Drew Altman explains how KFF is continually evolving to research, analyze and lead on health policy. Chip and Drew discuss how KFF’s new podcast will break down the business side of health care, artificial intelligence, and what it all means for health care delivery…
Real Estate Investors Profit From Long-Term Care While Residents Languish
By the time she was hospitalized in 2020, Pearlene Darby, a retired teacher, had suffered open sores on both legs, both hips, and both heels, as well as a five-inch-long gash on her tailbone. She died two weeks later at age 81 from infections and bedsores, according to her death certificate. Her daughter sued the…
Democrats Demand Trump Administration Halt Plan To Collect Federal Workers’ Health Data
Democratic lawmakers are demanding that the Trump administration halt plans to collect sensitive medical records for millions of federal workers and retirees, as well as their family members. The Office of Personnel Management has asked 65 insurance companies to provide monthly reports with detailed medical and pharmaceutical claims data of more than 8 million people…
Listen: Cheap Health Insurance Isn’t Always Cheap
High-deductible plans can look like a deal, until the bills start rolling in. On this episode of the NPR podcast Life Kit, reporter Jackie Fortiér breaks down what to expect and how to prepare. A lot of people choose their health insurance the way they shop for a flight — sort by the lowest price…
Philippe Pouletty, Carvolix
Philippe Pouletty is a physician who’s an inventor, French venture capitalist, and the founder of Carvolix. Carvolix is a medical technology company that is introducing AI into cardiology. Before Carvolix, Philippe was the founder of Abivax, which makes drugs for chronic inflammatory diseases like ulcerative colitis. He’s been working on helping French medical products develop…
Policy Expert Believes CMS is Taking “Adversial Posture” to Medicare Advantage
A consultant who has analyzed healthcare policy over many decades declares that MA is in the middle of a fundamental reset both in terms of market headwinds and federal scrutiny. The post Policy Expert Believes CMS is Taking “Adversial Posture” to Medicare Advantage appeared first on MedCity News.
UnitedHealthcare Expands Rural Healthcare Initiatives, Reduces Prior Auth Requirements
UnitedHealthcare is exempting rural providers from most prior authorization requirements. The post UnitedHealthcare Expands Rural Healthcare Initiatives, Reduces Prior Auth Requirements appeared first on MedCity News.
What is the purpose of cost sharing for cell & gene therapies?
This is the question that a recent AJMCcommentary by William Shrank, Ellen Kelsay, and Mark Fendrick aims to answer. When talking about cell and gene therapies, the authors argue that cost sharing is not being used to avoid unnecessary use of low value care, but rather as a form of rationing that creates disparities in…
Eli Lilly Makes Another In Vivo Genetic Medicines Move With $3.2B Kelonia Acquisition
Kelonia Therapeutics brings to Eli Lilly an in vivo cell therapy in early clinical development for multiple myeloma. The deal complements Lilly’s acquisitions of Verve Therapeutics and Orna Therapeutics in the past year, each taking different approaches to developing in vivo genetic medicines. The post Eli Lilly Makes Another In Vivo Genetic Medicines Move With…
How Employers Support Lower-Waged Workers’ Access to Health Insurance Options
Health insurance makes up 8% of total employee compensation on average, and while most employees take up health insurance when it is offered, lower-wage workers are far less likely to be able to access coverage, according to an analysis of survey data and focus groups with more than 100 U.S. employers with over a quarter…
